Antioxidants in chemoprevention of skin cancer.
Ahmad
N
N
Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.
Katiyar
S K
SK
Mukhtar
H
H
D000284:Administration, Oral; D000287:Administration, Topical; D000498:Allyl Compounds / Q000627:therapeutic use; D000818:Animals; D016588:Anticarcinogenic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D002273:Carcinogens / Q000633:toxicity; D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000517:prevention & control; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000528:radiation effects; D003043:Cocarcinogenesis; D003474:Curcumin / Q000627:therapeutic use; D005260:Female; D005419:Flavonoids; D020939:Zingiber officinale / Q000627:therapeutic use; D006801:Humans; D008297:Male; D051379:Mice; D018632:Mice, Inbred SENCAR; D009381:Neoplasms, Radiation-Induced / Q000378:metabolism / Q000517:prevention & control; D010212:Papilloma / Q000209:etiology / Q000517:prevention & control; D010636:Phenols / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D011108:Polymers / Q000627:therapeutic use; D017382:Reactive Oxygen Species; D000077185:Resveratrol; D012838:Silymarin / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D013267:Stilbenes / Q000627:therapeutic use; D013440:Sulfides / Q000627:therapeutic use; D013662:Tea / Q000737:chemistry; D014466:Ultraviolet Rays / Q000009:adverse effects
D000498:Allyl Compounds; D016588:Anticarcinogenic Agents; D000975:Antioxidants; D002273:Carcinogens; D005419:Flavonoids; D010636:Phenols; D011108:Polymers; D017382:Reactive Oxygen Species; D012838:Silymarin; D013267:Stilbenes; D013440:Sulfides; D013662:Tea; C038491:allyl sulfide; D003474:Curcumin; D000077185:Resveratrol